MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
12.77
+1.02 (8.68%)
At close: Nov 12, 2025, 4:00 PM EST
12.78
+0.01 (0.08%)
After-hours: Nov 12, 2025, 7:01 PM EST
MLTX Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$36.78
Upside
+188.02%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $30 | Hold → Strong Buy | Upgrades | $30 | +134.93% | Nov 3, 2025 |
| Citigroup | Citigroup | Hold → Strong Sell Downgrades $5 | Hold → Strong Sell | Downgrades | $5 | -60.85% | Oct 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $80 → $20 | Strong Buy | Maintains | $80 → $20 | +56.62% | Sep 30, 2025 |
| Wedbush | Wedbush | Buy Maintains $80 → $18 | Buy | Maintains | $80 → $18 | +40.96% | Sep 30, 2025 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $72 → $5 | Strong Buy → Hold | Downgrades | $72 → $5 | -60.85% | Sep 30, 2025 |
| Needham | Needham | Strong Buy Maintains $66 → $20 | Strong Buy | Maintains | $66 → $20 | +56.62% | Sep 30, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $67 → $10 | Buy → Hold | Downgrades | $67 → $10 | -21.69% | Sep 29, 2025 |
| BTIG | BTIG | Strong Buy → Hold Downgrades $85 | Strong Buy → Hold | Downgrades | $85 | +565.62% | Sep 29, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $74 → $82 | Strong Buy | Maintains | $74 → $82 | +542.13% | Aug 6, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $67 | Buy | Reiterates | $67 | +424.67% | Jun 3, 2025 |
| Wolfe Research | Wolfe Research | Hold → Buy Upgrades $61 | Hold → Buy | Upgrades | $61 | +377.68% | May 19, 2025 |
| Needham | Needham | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | +416.84% | May 13, 2025 |
| Needham | Needham | Strong Buy Reiterates $66 | Strong Buy | Reiterates | $66 | +416.84% | Apr 30, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $67 | Buy | Initiates | $67 | +424.67% | Mar 18, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $82 → $73 | Strong Buy | Maintains | $82 → $73 | +471.65% | Feb 27, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.